Dr. Dichek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 Ne Pacific St
# C212
Seattle, WA 98195Phone+1 206-685-6959
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1987
- David Geffen School of Medicine at UCLAClass of 1984
- Massachusetts General HospitalFellowship, Cardiovascular Disease
Certifications & Licensure
- CA State Medical License 1995 - Present
- WA State Medical License 2001 - 2026
- MA State Medical License 1986 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
Publications & Presentations
PubMed
- 383 citationsFas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destructionSang-Mo Kang, Darren B. Schneider, Zhonghua Lin, Douglas Hanahan, David A. Dichek
Nature Medicine. 1997-07-01 - 116 citationsLipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.Murielle M. Véniant, Constance H. Zlot, Rosemary L. Walzem, Vincenzo Pierotti, Robert M. Driscoll
The Journal of Clinical Investigation. 1998-10-15 - 130 citationsLocal adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury.Jeffrey J. Rade, Andrew H. Schulick, Renu Virmani, David A. Dichek
Nature Medicine. 1996-03-01
Press Mentions
- Baby Born with Severe Muscular Disease Shows Progress After Taking Experimental Drug at Seattle Children’s HospitalJune 1st, 2019
Grant Support
- A Proteomic Approach For Understanding Plaque RuptureNational Heart, Lung, And Blood Institute2012
- Cardiovascular Research Training ProgramNational Heart, Lung, And Blood Institute2002–2011
- Engineering Blood Vessels To Resist AtherosclerosisNational Heart, Lung, And Blood Institute2006–2009
- Mechanisms Of Urokinase-Induced Vascular DiseaseNational Heart, Lung, And Blood Institute2005–2009
- Transforming Growth Factor Betal And Arterial DiseaseNational Heart, Lung, And Blood Institute2001–2005
- Genetic Engineering Of Vascular TissueNational Heart, Lung, And Blood Institute2000–2002
- Genetic Engineering Of Vascular TissueNational Heart, Lung, And Blood Institute1998–2000
- Gene Transfer Approaches To Vascular Graft DiseaseNational Heart, Lung, And Blood Institute1998
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: